161 related articles for article (PubMed ID: 20621652)
41. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
Costa L
Breast; 2007 Dec; 16 Suppl 3():S16-20. PubMed ID: 18032044
[TBL] [Abstract][Full Text] [Related]
42. Moving into the future: treatment of bone metastases and beyond.
Hortobagyi GN
Cancer Treat Rev; 2005; 31 Suppl 3():9-18. PubMed ID: 16249057
[TBL] [Abstract][Full Text] [Related]
43. Emerging role for bisphosphonates in cancer management.
Chlebowski RT
Breast Dis; 2011; 33(2):55-7. PubMed ID: 22142659
[No Abstract] [Full Text] [Related]
44. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
45. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer.
Clemons M; Dranitsaris G; Cole D; Gainford MC
Oncologist; 2006 Mar; 11(3):227-33. PubMed ID: 16549806
[TBL] [Abstract][Full Text] [Related]
46. The role of bisphosphonates in early- and advanced-stage breast cancer: have we finally optimized care?
Blanchette PS; Pritchard KI
Oncology (Williston Park); 2015 Jan; 29(1):23-30, 37. PubMed ID: 25595283
[TBL] [Abstract][Full Text] [Related]
47. Bisphosphonates in breast cancer: a triple winner?
Mathew A; Brufsky A
Oncology (Williston Park); 2015 Jan; 29(1):37-9. PubMed ID: 25595284
[No Abstract] [Full Text] [Related]
48. Impact of Bone-Targeted Treatments on Skeletal Morbidity and Survival in Breast Cancer.
Coleman RE
Oncology (Williston Park); 2016 Aug; 30(8):695-702. PubMed ID: 27528238
[TBL] [Abstract][Full Text] [Related]
49. Bisphosphonates: game changers?
Craig Henderson I
Oncology (Williston Park); 2015 Jan; 29(1):16, 42. PubMed ID: 25595282
[No Abstract] [Full Text] [Related]
50. Improving the use of intravenous bisphosphonates in women with breast cancer metastatic to bone.
Mortimer J; Mendelsohn M
J Natl Compr Canc Netw; 2014 Feb; 12 Suppl 1():S40-1. PubMed ID: 24614052
[TBL] [Abstract][Full Text] [Related]
51. Cancer induced bone pain.
Kane CM; Hoskin P; Bennett MI
BMJ; 2015 Jan; 350():h315. PubMed ID: 25633978
[No Abstract] [Full Text] [Related]
52. Adjuvant Bone-Targeted Therapies for Postmenopausal Breast Cancer.
Wilson C; Coleman R
JAMA Oncol; 2016 Apr; 2(4):423-4. PubMed ID: 26794938
[No Abstract] [Full Text] [Related]
53. Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review.
Diel IJ
Support Care Cancer; 2007 Nov; 15(11):1243. PubMed ID: 17393190
[TBL] [Abstract][Full Text] [Related]
54. Prevention of bone metastases and management of bone health in early breast cancer.
Gnant M; Hadji P
Breast Cancer Res; 2010; 12(6):216. PubMed ID: 21172067
[TBL] [Abstract][Full Text] [Related]
55. Targeted therapy options for treatment of bone metastases; beyond bisphosphonates.
Buijs JT; Kuijpers CC; van der Pluijm G
Curr Pharm Des; 2010; 16(27):3015-27. PubMed ID: 20722621
[TBL] [Abstract][Full Text] [Related]
56. Bone health in breast cancer.
Pandey P; Sharma A; Gogia A
Curr Probl Cancer; 2023 Jun; 47(3):100959. PubMed ID: 37236055
[TBL] [Abstract][Full Text] [Related]
57. Emerging therapeutic targets in breast cancer bone metastasis.
Rose AA; Siegel PM
Future Oncol; 2010 Jan; 6(1):55-74. PubMed ID: 20021209
[TBL] [Abstract][Full Text] [Related]
58. Loving our bones.
Sledge GW
Clin Breast Cancer; 2009 May; 9(2):71. PubMed ID: 19433385
[No Abstract] [Full Text] [Related]
59. New strategies for the treatment of metastatic bone disease.
Pearse RN
Clin Breast Cancer; 2007 Dec; 8 Suppl 1():S35-45. PubMed ID: 18282368
[TBL] [Abstract][Full Text] [Related]
60. Cancer-associated bone disease.
Rizzoli R; Body JJ; Brandi ML; Cannata-Andia J; Chappard D; El Maghraoui A; Glüer CC; Kendler D; Napoli N; Papaioannou A; Pierroz DD; Rahme M; Van Poznak CH; de Villiers TJ; El Hajj Fuleihan G;
Osteoporos Int; 2013 Dec; 24(12):2929-53. PubMed ID: 24146095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
